Patriot Financial Group Insurance Agency’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-800
Closed -$421K 2136
2021
Q4
$527K Hold
800
0.09% 234
2021
Q3
$498K Hold
800
0.09% 236
2021
Q2
$505K Hold
800
0.09% 229
2021
Q1
$391K Hold
800
0.09% 234
2020
Q4
$400K Hold
800
0.1% 212
2020
Q3
$314K Hold
800
0.1% 195
2020
Q2
$264K Hold
800
0.1% 193
2020
Q1
$194K Hold
800
0.09% 218
2019
Q4
$209K Hold
800
0.08% 218
2019
Q3
$218K Buy
+800
New +$223K 0.1% 191
2019
Q2
Sell
-6
Closed -$1K 1449
2019
Q1
$1K Buy
+6
New +$1.24K ﹤0.01% 1125
2018
Q2
Sell
-800
Closed -$149K 733
2018
Q1
$149K Buy
800
+200
+33% +$36.9K 0.11% 164
2017
Q4
$99K Buy
600
+200
+50% +$31.5K 0.07% 213
2017
Q3
$63K Hold
400
0.06% 227
2017
Q2
$65K Hold
400
0.07% 208
2017
Q1
$62K Hold
400
0.07% 200
2016
Q4
$48K Buy
+400
New +$45.6K 0.07% 223

Other funds holding IDXX

Patriot Financial Group Insurance Agency's IDXX Position: Q1 2022 in Review

Patriot Financial Group Insurance Agency sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 800 shares — an estimated $421K sold.

Patriot Financial Group Insurance Agency first reported a position in IDXX in Q4 2016 and held it in 17 quarters. The position peaked at $527K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 800 Idexx Laboratories shares in Q1 2022, an estimated $421K.
  • Patriot Financial Group Insurance Agency first reported a position in Idexx Laboratories in Q4 2016 and held it in 17 quarters.
  • Patriot Financial Group Insurance Agency's Idexx Laboratories position peaked at $527K in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2022, filed 11 May 2022.